Reperio Health Company Profile
Background
Reperio Health, established in 2020 and headquartered in Portland, Oregon, is a pioneering digital health company specializing in at-home and onsite comprehensive health screenings that deliver instant results. The company's mission is to enhance community health by providing immediate and secure access to critical health data, thereby modernizing preventive care and making it more accessible and efficient.
Key Strategic Focus
Reperio Health focuses on delivering consumer-friendly, at-home biometric screenings that measure vital health metrics such as cholesterol, glucose levels, blood pressure, and more. By integrating FDA-cleared devices with a proprietary mobile application, the company offers a seamless screening experience that typically takes 30 minutes or less, with immediate results. This approach targets employers, healthcare providers, and payers, aiming to improve preventive care utilization and empower individuals with actionable health insights.
Financials and Funding
In April 2024, Reperio Health secured a $14 million funding round from existing investors. This capital infusion is intended to support the company's expansion into telehealth services and the establishment of additional distribution centers across the United States. The strategic focus is on enhancing product offerings and scaling operations to meet growing demand.
Pipeline Development
Reperio Health is actively expanding its product portfolio to address chronic and long-term disease management. In 2023, the company beta-tested an A1C screening offering, which was well-received and is slated for a broader rollout in 2024. This initiative underscores Reperio's commitment to providing comprehensive health screening solutions that cater to a wide range of health conditions.
Technological Platform and Innovation
Reperio Health's innovative platform combines a user-friendly mobile application with FDA-cleared devices to facilitate comprehensive at-home health screenings. The technology enables users to measure key health metrics and receive instant results, eliminating the need for lab processing. Guided video tutorials and 24/7 customer support enhance the user experience, ensuring accuracy and ease of use. Additionally, the company is developing an AI-assisted telehealth tool to provide virtual consultations, further integrating technology into preventive healthcare.
Leadership Team
- Travis Rush, Chief Executive Officer: Prior to founding Reperio Health, Travis established Sightbox, an all-inclusive vision care solution acquired by Johnson & Johnson in 2017. He has a background in technology and entrepreneurship, having launched Rushweb Solutions in 1997.
- Matt Wallington, Chief Technical Officer: With over 20 years of experience in technology, Matt has held positions at Amazon and Intel. He joined Travis at Sightbox to lead the engineering team and now oversees technological development at Reperio Health.
- Naomi Levinthal, Chief Growth Officer: Appointed in 2023, Naomi brings extensive experience in healthcare strategy and growth initiatives, focusing on expanding Reperio's market presence and partnerships.
Leadership Changes
In 2023, Reperio Health appointed Naomi Levinthal as the company's first Chief Growth Officer, marking a significant addition to the leadership team aimed at driving strategic growth and market expansion.
Competitor Profile
Market Insights and Dynamics
The at-home health screening market is experiencing significant growth, driven by increasing consumer demand for convenient and immediate health insights. The COVID-19 pandemic has accelerated the adoption of remote healthcare solutions, highlighting the need for accessible preventive care options.
Competitor Analysis
Key competitors in the at-home health screening space include companies like Everlywell and LetsGetChecked, which offer mail-in lab tests for various health conditions. However, Reperio Health differentiates itself by providing instant results through its integrated mobile app and FDA-cleared devices, eliminating the waiting period associated with lab processing.
Strategic Collaborations and Partnerships
Reperio Health has established several strategic partnerships to enhance its service offerings and expand its reach:
- Health Advocate: In February 2024, Health Advocate selected Reperio Health to offer comprehensive at-home biometric health screenings to its clients, integrating Reperio's services into its population health product offerings.
- Applied Health Analytics: In March 2024, Reperio partnered with Applied Health Analytics to provide health systems with immediate access to at-home biometric screening data, supporting employee health and reducing benefit expenses.
- US Wellness: In March 2022, Reperio collaborated with US Wellness to offer employers real-time at-home biometric screening technology, enhancing preventive care accessibility for employees.
Operational Insights
Reperio Health's strategic focus on delivering instant, at-home health screenings positions the company uniquely in the preventive care market. By eliminating traditional barriers such as scheduling and lab processing times, Reperio offers a compelling value proposition to employers, healthcare providers, and payers seeking efficient and user-friendly health assessment solutions.
Strategic Opportunities and Future Directions
Looking ahead, Reperio Health plans to expand its telehealth services, integrating AI-assisted virtual consultations to provide comprehensive care pathways following screenings. The company also aims to establish additional distribution centers to enhance logistics and meet increasing demand. Continued investment in product development, such as the upcoming A1C screening rollout, reflects Reperio's commitment to addressing a broad spectrum of health conditions and improving population health outcomes.
